Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
The Annals of Thoracic Surgery
|
July 1, 1988
Left ventricular aneurysm repair with myocardial revascularization: an analysis of 246 consecutive patients over 15 years
J N Vauthey, D W Berry, D W Snyder, et al.
Journal of Medicinal Chemistry
|
June 1, 1990
Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles
V G Matassa, T P Maduskuie, H S Shapiro, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2)
P Bridonneau, Y F Chang, D O'Connell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1993
Bronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig
P W Stengel, R D Dillard, H L Cho, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles
Y K Yee, P R Bernstein, E J Adams, et al.
The American Review of Respiratory Disease
|
April 1, 1990
The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist
R D Krell, D Aharony, C K Buckner, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides
V G Matassa, F J Brown, P R Bernstein, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor
J H Fleisch, C T Armstrong, C R Roman, et al.
European Journal of Pharmacology
|
July 18, 1996
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors
N Fox, M Song, J Schrementi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI
D W Snyder, N J Bach, R D Dillard, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
The Annals of Thoracic Surgery
|
July 1, 1988
Left ventricular aneurysm repair with myocardial revascularization: an analysis of 246 consecutive patients over 15 years
J N Vauthey, D W Berry, D W Snyder, et al.
Journal of Medicinal Chemistry
|
June 1, 1990
Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles
V G Matassa, T P Maduskuie, H S Shapiro, et al.
Journal of Medicinal Chemistry
|
April 4, 1998
High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2)
P Bridonneau, Y F Chang, D O'Connell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1993
Bronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig
P W Stengel, R D Dillard, H L Cho, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles
Y K Yee, P R Bernstein, E J Adams, et al.
The American Review of Respiratory Disease
|
April 1, 1990
The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist
R D Krell, D Aharony, C K Buckner, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides
V G Matassa, F J Brown, P R Bernstein, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor
J H Fleisch, C T Armstrong, C R Roman, et al.
European Journal of Pharmacology
|
July 18, 1996
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors
N Fox, M Song, J Schrementi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 23, 1999
Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI
D W Snyder, N J Bach, R D Dillard, et al.
Page
of 6